Brown Medical School
LETTERSSEARCHARCHIVESSUBSCRIBE


ABOUT IDCRADVISORY BOARDRELATED LINKSCONTACT US
ABOUT IDCR

IDCR, a forum for correctional problem solving, targets correctional administrators and HIV/AIDS and hepatitis care providers including physicians, nurses, outreach workers, and case managers. Continuing Medical Education credits are provided by Nova Southeastern University Health Professions Division (NSU) to physicians who accurately respond to the questions on the last page of the newsletter.

The editorial board and contributors to IDCR include national and regional correctional professionals, selected on the basis of their experience with HIV and hepatitis care in the correctional setting and their familiarity with current HIV and hepatitis treatment. We encourage submissions, feedback, and correspondence from our readership.

I M P O R T A N T   I N F O R M A T I O N

Over the past 10 years IDCR has strived to bring you the most up-to-date, relevant information on managing infectious diseases in the correctional setting. As we celebrate a decade of publication, we would like to personally thank you for your continued support and engagement. Unfortunately, this wi ll be IDCR’s last issue as an independent publication. While it is our every intention to continuing publishing issues under a new umbrella organization, these plans have yet to be determined. Please read the letter from the editor to learn more. Important Things to Know:

• Continuing medical education credit will continue to be available through August 2009. Please refer to the instructions and expiration date of the issue when applying for credit.

• All of our issues (February 1999-July/August 2008) will be available online at www.IDCROnline.org through 2014. Click on the Archives link at the top of the web page for a complete list of archived issues.

We have made these arrangements to allow maximum access to IDCR content during this time of uncertainty. We apologize for any confusion or inconvenience these changes may cause. If you have any questions feel free to contact me at (401)453-2068 or idcrme@gmail.com


ABOUT THIS CONTINUING EDUCATION ACTIVITY

NSU designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)T. Physicians should only claim credit commensurate with the extent of their participation in the activity. Statements of credit will be mailed within 6 to 8 weeks following the program.

To obtain credit read the Main Article, Spotlight and 101 sections of the monograph. When completed with both items download the PDF version
(click here to download free adobe reader) | (System requirements) of the monograph located on the sidebar and complete the post test, credit application and evaluation form at the end of the monograph. You must receive a test score of at least 75% and respond to all evaluation questions to receive a certificate. To receive your certificate mail or fax the post test, credit application and evaluation to:

IDCR 146 Clifford Street Providence, RI 02903
or fax it to (401)272-7562

The material presented in this activity does not reflect the views of NSU. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. NSU and IDCR do not recommend the use of any product outside of the labeled indications. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.



Release Date: 7-1-08
End Date: 8-30-09


COMMERCIAL SUPPORTERS

Gilead Sciences


OBJECTIVES

  • The learner will be able to explain the different types of FDA-approved rapid HIV tests, how they are used, and details related to their sensitivity and specificity.
  • The learner will be able to discuss how to communicate rapid HIV test results and how to incorporate HIV counseling with the rapid testing process.
  • The learner will be able to describe recent studies related to feasibility and cost analysis of rapid testing in jails.


PURPOSE STATEMENT AND TARGET AUDIENCE

The purpose of this monograph is to increase the knowledge of correctional health care providers on FDA-approved rapid HIV tests, communicating results offering HIV counseling for rapid testing, and on the benefits of implementing a rapid HIV testing program in a jail setting.



DISCLOSURES

Faculty Disclosure

NSU has no financial relationships to disclose.

In accordance with the Accreditation Council for NSU, the faculty for this activity has been asked to complete Conflict of Interest Disclosure forms.

Executive Editor
Anne S. De Groot, MD
Adjunct Associate Professor
Warren Alpert School of Medicine of Brown University

Nothing to Disclose

Editor in Chief
Joseph Bick, MD
Chief Deputy, Clinical Services California Medical Facility
California Department of Corrections

Nothing to Disclose

Deputy Editor
David Alain Wohl, MD
Associate Professor of Medicine
Division of Infectious Diseases
AIDS Clinical Research Unit
The University of North Carolina- Chapel Hill

Disclosures: Speaker: Abbott Laboraties, Gilead Sciences, Inc., Tibotec Therapeutics, Roche Pharmaceuticals, Merck & Co., Boehringer-Ingelheim, Bristol-Myers Sqibb.

Renee Ridzon, MD
Senior Program Officer
HIV, TB, Reproductive Health
Bill & Melinda Gates Foundation

Nothing to Disclose



Brooke E. Hoots, MSPH
The University of North Carolina School of Public Health

Disclosures: Nothing to disclose

David A. Wohl, MD
Associate Professor of Medicine
University of North Carolina
AIDS Clinical Research Unit

Disclosures: See above



  >  Click Here for Content

 

Back to Top

 

Infectious Diseases in
Corrections Report
Elizabeth Closson
Managing Editor
Infectious Disease in
Corrections Report
idcrme@gmail.com
www.idcronline.org
146 Clifford St.
Providence, RI 02903
ph. (401)453-2068
fax. (401)272-7562